A clinical case of successful application of a new treatment method for severe COVID-19
COVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Eco-vector
2020-08-01
|
| Series: | Клиническая практика |
| Subjects: | |
| Online Access: | https://journals.eco-vector.com/clinpractice/article/viewFile/34529/pdf_1 |
| _version_ | 1797717786823229440 |
|---|---|
| author | Alexander S. Samoylov Yuri D. Udalov Nikolai M. Kruglyakov Dmitry А. Terekhov German I. Bagzhanov Sergey S. Ochkin |
| author_facet | Alexander S. Samoylov Yuri D. Udalov Nikolai M. Kruglyakov Dmitry А. Terekhov German I. Bagzhanov Sergey S. Ochkin |
| author_sort | Alexander S. Samoylov |
| collection | DOAJ |
| description | COVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of bilateral polysegmental viral pneumonia, specific complications of which may include acute respiratory distress syndrome, resulting in the respiratory failure with a high risk of death. Due to the absence of etiotropic therapy for the coronavirus infection, pathogentic treatment becomes of primary importance. We present a clinical case of a severe form of COVID-19 in a 33-year-old man to whom we administered a new method of pathogenetic treatment of this disease based on immunosuppresiive therapy followed by therapeutic plasma exchange and infusion of non-specific human immunoglobulin. |
| first_indexed | 2024-03-12T08:41:26Z |
| format | Article |
| id | doaj.art-fc0f3636869b439aa6dbcdeade7457e4 |
| institution | Directory Open Access Journal |
| issn | 2220-3095 2618-8627 |
| language | English |
| last_indexed | 2024-03-12T08:41:26Z |
| publishDate | 2020-08-01 |
| publisher | Eco-vector |
| record_format | Article |
| series | Клиническая практика |
| spelling | doaj.art-fc0f3636869b439aa6dbcdeade7457e42023-09-02T16:49:59ZengEco-vectorКлиническая практика2220-30952618-86272020-08-011129310010.17816/clinpract3452931334A clinical case of successful application of a new treatment method for severe COVID-19Alexander S. Samoylov0https://orcid.org/0000-0002-9241-7238Yuri D. Udalov1https://orcid.org/0000-0002-9739-8478Nikolai M. Kruglyakov2https://orcid.org/0000-0001-5011-6288Dmitry А. Terekhov3German I. Bagzhanov4https://orcid.org/0000-0003-3363-5195Sergey S. Ochkin5https://orcid.org/0000-0001-8103-4963State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyState Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological AgencyCOVID-19, formerly coronavirus infection 2019-nCoV, is a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV). It is a dangerous disease that can occur both in the form of a mild acute respiratory viral infection and in a severe form with the development of bilateral polysegmental viral pneumonia, specific complications of which may include acute respiratory distress syndrome, resulting in the respiratory failure with a high risk of death. Due to the absence of etiotropic therapy for the coronavirus infection, pathogentic treatment becomes of primary importance. We present a clinical case of a severe form of COVID-19 in a 33-year-old man to whom we administered a new method of pathogenetic treatment of this disease based on immunosuppresiive therapy followed by therapeutic plasma exchange and infusion of non-specific human immunoglobulin.https://journals.eco-vector.com/clinpractice/article/viewFile/34529/pdf_1covid-19selective plasma filtrationimmunosuppressionplasma exchangecase report |
| spellingShingle | Alexander S. Samoylov Yuri D. Udalov Nikolai M. Kruglyakov Dmitry А. Terekhov German I. Bagzhanov Sergey S. Ochkin A clinical case of successful application of a new treatment method for severe COVID-19 Клиническая практика covid-19 selective plasma filtration immunosuppression plasma exchange case report |
| title | A clinical case of successful application of a new treatment method for severe COVID-19 |
| title_full | A clinical case of successful application of a new treatment method for severe COVID-19 |
| title_fullStr | A clinical case of successful application of a new treatment method for severe COVID-19 |
| title_full_unstemmed | A clinical case of successful application of a new treatment method for severe COVID-19 |
| title_short | A clinical case of successful application of a new treatment method for severe COVID-19 |
| title_sort | clinical case of successful application of a new treatment method for severe covid 19 |
| topic | covid-19 selective plasma filtration immunosuppression plasma exchange case report |
| url | https://journals.eco-vector.com/clinpractice/article/viewFile/34529/pdf_1 |
| work_keys_str_mv | AT alexanderssamoylov aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT yuridudalov aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT nikolaimkruglyakov aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT dmitryaterekhov aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT germanibagzhanov aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT sergeysochkin aclinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT alexanderssamoylov clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT yuridudalov clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT nikolaimkruglyakov clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT dmitryaterekhov clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT germanibagzhanov clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 AT sergeysochkin clinicalcaseofsuccessfulapplicationofanewtreatmentmethodforseverecovid19 |